Artificial Intelligence is the theme of the upcoming INVEST Digital Health conference at Pegasus Park in Dallas on September 18. As the healthcare industry gets to know AI technology through pilots, clinical validation is critical for understanding the technology’s limitations. Organizations are realizing that hallucinations generated by AI not only reveal the Achilles’ Heel of the technology but also poses a challenge for how to eliminate this irksome problem.

Two panels at INVEST Digital Health will explore these issues.

Beyond the Buzzwords: Evaluating AI Tools’ Efficacy and ROI will look at what it takes to prove an AI tool’s

worth, as well as explore the growing demand for third-party validation and peer-reviewed evidence. Among the panelists are:

Michael Kalishman, Chief Ven

See Full Page